VIPoma differential diagnosis: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}}{{Homa}} | {{CMG}}{{AE}}{{MSI}}{{PSD}}{{Homa}} | ||
==Overview== | ==Overview== | ||
VIPoma must be differentiated from ganglioneuroblastoma, [[ganglioneuroma]], factitious [[diarrhea]], | VIPoma must be differentiated from ganglioneuroblastoma, [[ganglioneuroma]], factitious [[diarrhea]], [[bile salt]] [[enteropathy]], [[rectal]] vilous [[adenomas]], and [[laxative abuse]]. | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Line 9: | Line 9: | ||
*Ganglioneuroblastoma | *Ganglioneuroblastoma | ||
*[[Ganglioneuroma]] | *[[Ganglioneuroma]] | ||
*[[Enterotoxin]] production by Vibrio cholera and [[E.coli]] | *[[Enterotoxin]] production by [[Vibrio cholerae|Vibrio cholera]] and [[E.coli]] | ||
*Rectal vilous adenomas | *[[Rectal]] vilous [[adenomas]] | ||
*Bile salt | *[[Bile salts|Bile salt]] [[enteropathy]] | ||
*Factitious [[diarrhea]] | *Factitious [[diarrhea]] | ||
*[[Laxative abuse]] | *[[Laxative abuse]]<small>'''The table below summarizes the findings that differentiate watery causes of chronic diarrhea'''<ref name="pmid16151544">{{cite journal| author=Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.| title=Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. | journal=Can J Gastroenterol | year= 2005 | volume= 19 Suppl A | issue= | pages= 5A-36A | pmid=16151544 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16151544 }} </ref><ref name="pmid12135027">{{cite journal| author=Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D| title=Bowel habits and bile acid malabsorption in the months after cholecystectomy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 7 | pages= 1732-5 | pmid=12135027 | doi=10.1111/j.1572-0241.2002.05779.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12135027 }} </ref><ref name="pmid1702075">{{cite journal| author=Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R et al.| title=Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. | journal=Gastroenterology | year= 1991 | volume= 100 | issue= 2 | pages= 359-69 | pmid=1702075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1702075 }} </ref><ref name="pmid14439871">{{cite journal| author=RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC| title=Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. | journal=Gastroenterology | year= 1960 | volume= 38 | issue= | pages= 28-49 | pmid=14439871 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14439871 }} </ref> | ||
'''The table below summarizes the findings that differentiate watery causes of chronic diarrhea'''<ref name="pmid16151544">{{cite journal| author=Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.| title=Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. | journal=Can J Gastroenterol | year= 2005 | volume= 19 Suppl A | issue= | pages= 5A-36A | pmid=16151544 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16151544 }} </ref><ref name="pmid12135027">{{cite journal| author=Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D| title=Bowel habits and bile acid malabsorption in the months after cholecystectomy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 7 | pages= 1732-5 | pmid=12135027 | doi=10.1111/j.1572-0241.2002.05779.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12135027 }} </ref><ref name="pmid1702075">{{cite journal| author=Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R et al.| title=Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. | journal=Gastroenterology | year= 1991 | volume= 100 | issue= 2 | pages= 359-69 | pmid=1702075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1702075 }} </ref><ref name="pmid14439871">{{cite journal| author=RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC| title=Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. | journal=Gastroenterology | year= 1960 | volume= 38 | issue= | pages= 28-49 | pmid=14439871 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14439871 }} </ref | |||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="3" rowspan="2" |Cause | ! colspan="3" rowspan="2" |Cause | ||
Line 34: | Line 31: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
* [[Abdominal pain]] followed by [[diarrhea]] | *[[Abdominal pain]] followed by [[diarrhea]] | ||
| | | | ||
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | *[[Abdominal]] [[tenderness ]]when palpated in severe [[disease]] | ||
* Blood seen on [[rectal exam]] | * Blood seen on [[rectal exam]] | ||
*[[Fever]] | *[[Fever]] | ||
Line 42: | Line 39: | ||
*[[Hypotension]] | *[[Hypotension]] | ||
| | | | ||
* [[Colonoscopy]] with [[biopsy]] | *[[Colonoscopy]] with [[biopsy]] | ||
| | | | ||
* Topical mucosamine and [[corticosteroids]] are preferred | * Topical mucosamine and [[corticosteroids]] are preferred | ||
* [[Mesalamine]] and [[sulfasalazine]] are used for remission | *[[Mesalamine]] and [[sulfasalazine]] are used for remission | ||
|- | |- | ||
|[[Hyperthyroidism]] | |[[Hyperthyroidism]] | ||
Line 53: | Line 50: | ||
* Excessive [[sweating]] | * Excessive [[sweating]] | ||
* Heat intolerance | * Heat intolerance | ||
* [[Hypermotility|Increased bowel movements]] | *[[Hypermotility|Increased bowel movements]] | ||
| | | | ||
* Lump in the neck | * Lump in the neck | ||
* [[Proptosis]] | *[[Proptosis]] | ||
* [[Tremors]] | *[[Tremors]] | ||
* Increased DTR | * Increased DTR | ||
| | | | ||
* [[TSH]] with [[T3]] and [[T4]] | *[[TSH]] with [[T3]] and [[T4]] | ||
| | | | ||
* [[Carbimazole]] and [[methimazole]] | *[[Carbimazole]] and [[methimazole]] | ||
* [[Beta blockers]] like [[propylthiouracil]] | *[[Beta blockers]] like [[propylthiouracil]] | ||
* [[Iodine-131]] | *[[Iodine-131]] | ||
|- | |- | ||
|[[VIPoma]] | |[[VIPoma]] | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
| | | | ||
* Watery [[diarrhea]] | * Watery [[diarrhea]] | ||
* [[Dehydration]] ([[thirst]], [[dry skin]], [[dry mouth]], [[tiredness]], [[headaches]], and [[dizziness]]) | *[[Dehydration]] ([[thirst]], [[dry skin]], [[dry mouth]], [[tiredness]], [[headaches]], and [[dizziness]]) | ||
* [[Lethargy]], [[muscle weakness]] | *[[Lethargy]], [[muscle weakness]] | ||
* [[Nausea]], [[vomiting]] | *[[Nausea]], [[vomiting]] | ||
* Crampy [[abdominal pain]] | * Crampy [[abdominal pain]] | ||
* [[Weight loss]] | *[[Weight loss]] | ||
* [[Flushing]] | *[[Flushing]] | ||
| | | | ||
* [[Tachycardia]] | *[[Tachycardia]] | ||
* [[Rash]] | *[[Rash]] | ||
* [[Facial flushing]] | *[[Facial flushing]] | ||
* [[Abdominal distention]] | *[[Abdominal distention]] | ||
* [[Abdominal tenderness]] in the right upper abdominal quadrant | *[[Abdominal tenderness]] in the right upper abdominal quadrant | ||
| | | | ||
* Elevated [[VIP]] levels | * Elevated [[VIP]] levels | ||
* Followed by imaging | * Followed by imaging | ||
| | | | ||
* [[Sandostatin]] or [[chemotherapy]] for [[malignant tumors]] | *[[Sandostatin]] or [[chemotherapy]] for [[malignant tumors]] | ||
* Surgical removal of the [[tumor]] | * Surgical removal of the [[tumor]] | ||
|- | |- | ||
| rowspan="2" |[[Osmotic]] | | rowspan="2" |[[Osmotic]] | ||
|[[Lactose intolerance]] | |[[Lactose intolerance]] | ||
| - | | - | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
:* [[Abdominal pain]] | :*[[Abdominal pain]] | ||
:* [[Bloating]] | :*[[Bloating]] | ||
:* [[Diarrhea]] | :*[[Diarrhea]] | ||
:* [[Flatulence]] | :*[[Flatulence]] | ||
| | | | ||
* [[Abdominal tenderness]] | *[[Abdominal tenderness]] | ||
| | | | ||
* Intestinal [[biopsy]] | * Intestinal [[biopsy]] | ||
Line 111: | Line 108: | ||
|- | |- | ||
|[[Celiac disease (patient information)|Celiac disease]] | |[[Celiac disease (patient information)|Celiac disease]] | ||
| - | | - | ||
| + | | + | ||
| | | | ||
* May be asymptomatic | * May be asymptomatic | ||
* Vague [[abdominal pain]] | * Vague [[abdominal pain]] | ||
* [[Diarrhea]] | *[[Diarrhea]] | ||
* [[Weight loss]] | *[[Weight loss]] | ||
* [[Malabsorption]] / [[steatorrhea]] | *[[Malabsorption]] / [[steatorrhea]] | ||
* Bloatedness | * Bloatedness | ||
| | | | ||
* [[Abdominal pain]] and [[cramping]] | *[[Abdominal pain]] and [[cramping]] | ||
* [[Abdominal distention]] | *[[Abdominal distention]] | ||
* [[Tetany]] | *[[Tetany]] | ||
* [[Mouth ulcers]] | *[[Mouth ulcers]] | ||
* [[Dermatitis herpetiformis]] | *[[Dermatitis herpetiformis]] | ||
* Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency | * Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency | ||
| | | | ||
* [[IgA]] tissue [[transglutaminase]] Ab | *[[IgA]] tissue [[transglutaminase]] Ab | ||
| | | | ||
* [[Gluten-free diet]] | *[[Gluten-free diet]] | ||
|- | |- | ||
| | | | ||
|Functional | |Functional | ||
|[[Irritable bowel syndrome]] | |[[Irritable bowel syndrome]] | ||
| - | | - | ||
| - | | - | ||
| | | | ||
[[Abdominal pain]] or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following: | [[Abdominal pain]] or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following: | ||
* Improves with [[defecation]] | * Improves with [[defecation]] | ||
Line 146: | Line 144: | ||
* 25% of [[Bowel movement|bowel movements]] are loose stools | * 25% of [[Bowel movement|bowel movements]] are loose stools | ||
History of straining is also common | History of straining is also common | ||
| | | | ||
* [[Abdominal tenderness]] | *[[Abdominal tenderness]] | ||
* Hard stool in the rectal vault | * Hard stool in the rectal vault | ||
| | | | ||
* [[Diagnosis|Clinical diagnosis]] | *[[Diagnosis|Clinical diagnosis]] | ||
** ROME III criteria | ** ROME III criteria | ||
** [[Pharmacological|Pharmacologic]] studies based criteria | **[[Pharmacological|Pharmacologic]] studies based criteria | ||
| | | | ||
* High [[dietary fiber]] | * High [[dietary fiber]] | ||
* [[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]] | *[[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]] | ||
* [[Antispasmodic]] drugs (e.g. [[Anticholinergic|anticholinergics]] such as [[hyoscyamine]] or [[dicyclomine]]) | *[[Antispasmodic]] drugs (e.g. [[Anticholinergic|anticholinergics]] such as [[hyoscyamine]] or [[dicyclomine]]) | ||
|}{{WikiDoc Help Menu}} {{WikiDoc Sources}} | |}{{WikiDoc Help Menu}} {{WikiDoc Sources}} | ||
<small> | <small> | ||
Line 178: | Line 177: | ||
|- | |- | ||
|Zollinger-Ellison syndrome | |Zollinger-Ellison syndrome | ||
| + | | + | ||
| - | | - | ||
| | | | ||
* [[Abdominal pain]] and [[diarrhea]] | *[[Abdominal pain]] and [[diarrhea]] | ||
* [[Dyspepsia]] | *[[Dyspepsia]] | ||
* Upper or Lower [[gastrointestinal bleeding]] | * Upper or Lower [[gastrointestinal bleeding]] | ||
| | | | ||
* [[Abdominal]] [[tenderness]] | *[[Abdominal]] [[tenderness]] | ||
* [[Hematochezia]] | *[[Hematochezia]] | ||
* [[Hematemesis]] | *[[Hematemesis]] | ||
* [[Tachycardia]] | *[[Tachycardia]] | ||
* [[Hypotension]] | *[[Hypotension]] | ||
|[[Gastrin]] levels | |[[Gastrin]] levels | ||
|- | |- | ||
Line 197: | Line 196: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
* [[Abdominal pain]] followed by [[diarrhea]] | *[[Abdominal pain]] followed by [[diarrhea]] | ||
| | | | ||
* [[Abdominal]] [[tenderness]] when palpated in severe [[disease]] | *[[Abdominal]] [[tenderness]] when palpated in severe [[disease]] | ||
* Blood seen on [[rectal exam]] | * Blood seen on [[rectal exam]] | ||
*[[Fever]] | *[[Fever]] | ||
Line 207: | Line 206: | ||
| | | | ||
* [[Colonoscopy]] with [[biopsy]] | *[[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
Line 217: | Line 216: | ||
* Excessive [[sweating]] | * Excessive [[sweating]] | ||
* Heat intolerance | * Heat intolerance | ||
* [[Hypermotility|Increased bowel movements]] | *[[Hypermotility|Increased bowel movements]] | ||
| | | | ||
* Lump in the neck | * Lump in the neck | ||
* [[Proptosis]] | *[[Proptosis]] | ||
* [[Tremors]] | *[[Tremors]] | ||
* Increased DTR | * Increased DTR | ||
| | | | ||
* [[TSH]] with [[T3]] and [[T4]] | *[[TSH]] with [[T3]] and [[T4]] | ||
|- | |- | ||
Line 232: | Line 231: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
| | | | ||
* Watery [[diarrhea]] | * Watery [[diarrhea]] | ||
* [[Dehydration]] ([[thirst]], [[dry skin]], [[dry mouth]], [[tiredness]], [[headaches]], and [[dizziness]]) | *[[Dehydration]] ([[thirst]], [[dry skin]], [[dry mouth]], [[tiredness]], [[headaches]], and [[dizziness]]) | ||
* [[Lethargy]], [[muscle weakness]] | *[[Lethargy]], [[muscle weakness]] | ||
* [[Nausea]], [[vomiting]] | *[[Nausea]], [[vomiting]] | ||
* Cramping [[abdominal pain]] | * Cramping [[abdominal pain]] | ||
* [[Weight loss]] | *[[Weight loss]] | ||
* [[Flushing]] | *[[Flushing]] | ||
| | | | ||
* [[Tachycardia]] | *[[Tachycardia]] | ||
* [[Rash]] | *[[Rash]] | ||
* [[Facial flushing]] | *[[Facial flushing]] | ||
* [[Abdominal distention]] | *[[Abdominal distention]] | ||
* [[Abdominal tenderness]] in the right upper abdominal quadrant | *[[Abdominal tenderness]] in the right upper abdominal quadrant | ||
| | | | ||
Line 258: | Line 257: | ||
|[[Lactose intolerance]] | |[[Lactose intolerance]] | ||
| - | | - | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* [[Abdominal pain]] | *[[Abdominal pain]] | ||
* [[Bloating]] | *[[Bloating]] | ||
* [[Diarrhea]] | *[[Diarrhea]] | ||
* [[Flatulence]] | *[[Flatulence]] | ||
| | | | ||
* [[Abdominal tenderness]] | *[[Abdominal tenderness]] | ||
| | | | ||
Line 276: | Line 275: | ||
|[[Celiac disease (patient information)|Celiac disease]] | |[[Celiac disease (patient information)|Celiac disease]] | ||
| - | | - | ||
| + | | + | ||
| | | | ||
* May be [[asymptomatic]] | * May be [[asymptomatic]] | ||
* Vague [[abdominal pain]] | * Vague [[abdominal pain]] | ||
* [[Diarrhea]] | *[[Diarrhea]] | ||
* [[Weight loss]] | *[[Weight loss]] | ||
* [[Malabsorption]]/[[steatorrhea]] | *[[Malabsorption]]/[[steatorrhea]] | ||
* Bloatedness | * Bloatedness | ||
| | | | ||
* [[Abdominal pain]] and [[cramping]] | *[[Abdominal pain]] and [[cramping]] | ||
* [[Abdominal distention]] | *[[Abdominal distention]] | ||
* [[Tetany]] | *[[Tetany]] | ||
* [[Mouth ulcers]] | *[[Mouth ulcers]] | ||
* [[Dermatitis herpetiformis]] | *[[Dermatitis herpetiformis]] | ||
* Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency | * Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency | ||
| | | | ||
* [[IgA]] tissue [[transglutaminase]] Ab | *[[IgA]] tissue [[transglutaminase]] Ab | ||
|- | |- | ||
|[[Irritable bowel syndrome]] | |[[Irritable bowel syndrome]] | ||
| - | | - | ||
| - | | - | ||
| | | | ||
Line 320: | Line 319: | ||
| | | | ||
* [[Abdominal tenderness]] | *[[Abdominal tenderness]] | ||
* Hard [[stool]] in the rectal vault | * Hard [[stool]] in the rectal vault | ||
| | | | ||
* [[Diagnosis|Clinical diagnosis]] | *[[Diagnosis|Clinical diagnosis]] | ||
** ROME III criteria | ** ROME III criteria | ||
** [[Pharmacological|Pharmacologic]] studies based criteria | **[[Pharmacological|Pharmacologic]] studies based criteria | ||
|} | |} | ||
Line 337: | Line 336: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Medicine]] | |||
<br />[[Category:Medicine]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] |
Revision as of 16:58, 4 October 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3] Homa Najafi, M.D.[4]
Overview
VIPoma must be differentiated from ganglioneuroblastoma, ganglioneuroma, factitious diarrhea, bile salt enteropathy, rectal vilous adenomas, and laxative abuse.
Differential Diagnosis
VIPoma must be differentiated from:[1]
- Ganglioneuroblastoma
- Ganglioneuroma
- Enterotoxin production by Vibrio cholera and E.coli
- Rectal vilous adenomas
- Bile salt enteropathy
- Factitious diarrhea
- Laxative abuseThe table below summarizes the findings that differentiate watery causes of chronic diarrhea[2][3][4][5]
Cause | Osmotic gap | History | Physical exam | Gold standard | Treatment | |||
---|---|---|---|---|---|---|---|---|
< 50 mOsm per kg | > 50 mOsm per kg* | |||||||
Watery | Secretory | Crohns | + | - |
|
|
|
|
Hyperthyroidism | + | - |
|
|||||
VIPoma | + | - |
|
|
|
| ||
Osmotic | Lactose intolerance | - | + |
|
||||
Celiac disease | - | + |
|
|
|
|||
Functional | Irritable bowel syndrome | - | - |
Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:
History of straining is also common |
|
|
|
VIPoma must be differentiated from diseases that cause abdominal pain and chronic diarrhea. The table below summarizes the findings that differentiate watery causes of chronic diarrhea:[6][2][3][4][5]
Cause | Osmotic gap | History | Physical exam | Gold standard for diagnosis | |
---|---|---|---|---|---|
< 50 mOsm per kg | > 50 mOsm per kg* | ||||
Zollinger-Ellison syndrome | + | - |
|
Gastrin levels | |
Crohn's disease | + | - |
|
|
|
Hyperthyroidism | + | - |
|
||
VIPoma | + | - |
|
|
|
Lactose intolerance | - | + |
| ||
Celiac disease | - | + |
|
|
|
Irritable bowel syndrome | - | - |
Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:
History of straining is also common. |
|
|
References
- ↑ Reindl T, Degenhardt P, Luck W, Riebel T, Sarioglu N, Henze G; et al. (2004). "[The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics]". Klin Padiatr. 216 (5): 264–9. doi:10.1055/s-2004-44901. PMID 15455292.
- ↑ 2.0 2.1 Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ 3.0 3.1 Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ 4.0 4.1 Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ 5.0 5.1 RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.